PHIO Phio Pharmaceuticals Corp. Net Sales Margin

Public company logo of Phio Pharmaceuticals Corp. (PHIO)

The net margin efficiency of Phio Pharmaceuticals, as presented by the GURU.Markets platform, demonstrates the resilience of a model where 0.00 is the current value of the indicator. Phio Pharmaceuticals is developing RNA interference via the INTASYL platform, creating exclusive treatment protocols. The team brings together leading cancer geneticists who possess academic freedom. The technology stack is supplemented by robotic molecule screening and predictive software.

PHIO: Phio Pharmaceuticals Corp Net Sales Margin 07/04/2022 - 11/19/2026

Summary analytical data breakdowns for phiopharma.com (PHIO)

- share price and expert price forecast:
Basic company analysis:RXi Pharmaceuticals - PHIO
Flagship merchandise of Phio Pharmaceuticals

Net margin is calculated as the ratio of net profit to total revenue. This coefficient measures cost management efficiency and the fundamental profitability of each unit of sales. For Phio Pharmaceuticals (PHIO), this metric reflects the development costs of the INTASYL RNA interference platform within the context of immuno-oncology. The trend in annual net margin allows investors to filter out speculative noise from real growth in operational efficiency. The trajectory of the annual net margin determines the balance between potential returns and the risk of overpayment.

Competitor analysis

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|RCKT: Return on Sales by Net Profit|FDMT - Net Sales Margin|LXEO: Net Sales Margin|Korro Bio Inc. - Net Profit Rate|EDIT (editasmedicine.com) - Net Sales Margin|Net Margin SLN|Net Margin ProQR Therapeutics NV (PRQR)|Codexis - Net Return on Sales|Net Margin Sangamo SGMO|NAUT: Net Return on Sales|MGX: Return on Sales by Net Profit|Net Margin Precision BioSciences|GBIO (generationbio.com) - Return on Sales by Net Profit|Net Margin boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Net Sales Margin|Net Return on Sales IMNN (Imunon, Inc.)|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX